RAGE fusion proteins and methods of use

Details for Australian Patent Application No. 2005271449 (hide)

Owner TransTech Pharma, Inc. The Trustees of Columbia University in the City of New York

Inventors Stern, David M.; Webster, Jeffrey C.; Mjalli, Adnan M.M.; Yan, Shi Du; Schmidt, Ann Marie; Tian, Ye E.; Rothlein, Robert

Agent Spruson & Ferguson

Pub. Number AU-A-2005271449

PCT Pub. Number WO2006/017643

Priority 60/598,362 03.08.04 US

Filing date 3 August 2005

Wipo publication date 16 February 2006

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/017643 Priority application(s): WO2006/017643

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271452-RAGE fusion proteins and methods of use

2005271445-Crystalline polymorph of pipindoxifene hydrochloride monohydrate